Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association. [electronic resource]
- Circulation Jul 2013
- 281-308 p. digital
Publication Type: Journal Article; Practice Guideline
1524-4539
10.1161/CIR.0b013e31829b2be6 doi
American Heart Association Consensus Heart Failure--etiology Humans Iron Chelating Agents--therapeutic use Iron Overload--complications United States beta-Thalassemia--complications